STAT
APRIL 17, 2025
UnitedHealth Group on Thursday lowered its profit outlook for the rest of this year after the health care conglomerate said its Medicare Advantage members continued to seek more medical care than it anticipated. The higher use of care among these Medicare enrollees “was most notable within physician and outpatient services,” UnitedHealth said in its first-quarter earnings release.
Putting Patients First Blog
APRIL 17, 2025
NHC Letter to Congress: Protect Medicaid Access for Americans with Chronic Conditions and Disabilities (PDF) April 17, 2025 The Honorable John Thune The Honorable Chuck Schumer Majority Leader Minority Leader United States Senate United States Senate Washington, DC 20510 Washington, DC 20510 The Honorable Mike Johnson The Honorable Hakeem Jeffries Speaker Minority Leader U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 17, 2025
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them with patients and caregivers, Commissioner Marty Makary announced Thursday. While that’s not really a big change, it’s the latest effort by Makary and his boss, health secretary Robert F. Kennedy Jr., to reduce the influence of the pharmaceutical industry.
Quality Matters
APRIL 17, 2025
Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S. come from India and the European Union This blog is part of a series on the geographic concentration of pharmaceutical manufacturing. This blog focuses on the manufacturing of active pharmaceutical ingredients (API). For a discussion on finished dose manufacturing, seehere.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
PharmaVoice
APRIL 17, 2025
The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
APRIL 17, 2025
More than 37 million adults in the US are affected by migraine
Pharmaceutical Business Review
APRIL 17, 2025
The funding round was spearheaded by CTI Life Sciences Fund, Advent Life Sciences, and abrdn-managed funds. Current investors, including Sanofi Ventures, Novo Holdings, RiverVest Venture Partners, Sanderling Ventures, Abingworth, Chiesi Ventures, Asahi Kasei Ventures, and Remiges Ventures, also participated in the round. Glycomine noted that the therapy is being developed to treat the rare and potentially fatal phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG).
Drug Patent Watch
APRIL 17, 2025
"Patent Use Codes: The Hidden Language of Pharmaceutical Innovation As a healthcare professional, have you ever wondered what lies behind the complex world of patent use codes? These seemingly obscure codes hold the key to understanding the intricacies of pharmaceutical innovation and the strategies employed by manufacturers to protect their intellectual property.
PharmaVoice
APRIL 17, 2025
The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
APRIL 17, 2025
Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit
The Pharmacist
APRIL 17, 2025
Up to 200 additional pharmacies will be able to offer the respiratory syncytial virus (RSV) immunisation programme during 2025/26, under new plans announced by NHS England. This is on top of the around 40 community pharmacy sites that currently offer the national programme which is open to older adults and pregnant women. The update comes […] The post NHSE to expand community pharmacy RSV vaccine offer appeared first on The Pharmacist.
EMCrit Project
APRIL 17, 2025
Neuroleptic Malignant Syndrome (NMS) and Serotonin Syndrome (SS) are relucatantly covered on this week's show EMCrit Project by Scott Weingart, MD FCCM.
pharmaphorum
APRIL 17, 2025
A complaint against GSK alleging a major breach of the pharma industry's code of practice on prescribing information has been upheld by the PMCPA
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
BioPharma Dive
APRIL 17, 2025
The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, swelling Lilly's market value by more than $100 billion.
pharmaphorum
APRIL 17, 2025
Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron
World Pharma News
APRIL 17, 2025
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimers disease and related dementias in patients with Type 2 diabetes. In research published in JAMA Neurology on April 7, UF researchers studied Medicare claims data of older adults with Type 2 diabetes to assess the association among glucagon-like peptide-1 receptor agonists, or GLP-1RAs, sodium-gluc
pharmaphorum
APRIL 17, 2025
Our round-up of recent biotech financings includes rounds for Merida, Glycomine, Attovia, Imbria, and Solu Therapeutics.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
APRIL 17, 2025
What are the major advancements in drug development research? What are the opportunities for India in the current landscape? Drug development research has made remarkable progress globally, with India emerging as a key contributor. According to Deloitte, Indias pharmaceutical research and development (R&D) market is estimated to expand to $130 billion by 2030, and the country is considered the third-largest global producer of drugs by volume (1).
pharmaphorum
APRIL 17, 2025
Spruce has bounced back from the failure of its lead drug last year, thanks to a licensing deal with BioMarin for a late-stage Sanfilippo drug
The Script
APRIL 17, 2025
Explore how self-leadership empowers pharmacy professionals to grow, lead, and deliver better care. Find your next opportunity with Rx relief.
Express Pharma
APRIL 17, 2025
The Ministry of Health and Family Welfare introduced a new mandate for the top 300 drugs in India to carry a QR code, which upon scanning by an inspector or consumer would provide instant details of that medicine and its manufacturer. The objective of this program is to protect consumers by detecting counterfeit medicines in the market. As I have argued however, the program rests on the false notion that QR codes represent a suitable data carrier for this program when in fact they are highly sus
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Commerce
APRIL 17, 2025
The interchangeability designation for Yuflyma, a biosimilar to Humira, may help to improve patient access and reduce costs.
BioPharma Dive
APRIL 17, 2025
The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at multiple popular immune disease targets, such as TL1A and IL23.
Pharmaceutical Commerce
APRIL 17, 2025
Will Robinson, program director, LogiPharma, shares how in-depth conversationsnot AIdrive the research behind one of the industry's most anticipated annual agendas.
PharmExec
APRIL 17, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
APRIL 17, 2025
Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in 2026.
PharmExec
APRIL 17, 2025
A new study found that patients with type 2 diabetes treated with GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors demonstrated lower risks of developing Alzheimer disease compared to other glucose-lowering drugs.
Pharmaceutical Commerce
APRIL 17, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & Dickson and chair of HDAs board of directors, explains how he foresees the future of the organization, along with the role he hopes to play in shaping its direction.
Expert insights. Personalized for you.
343 
Let's personalize your content